Download PDF
Nuklearmedizin 2018; 57(02): N10-N12
DOI: 10.1055/s-0038-1641692
Case Report
Schattauer GmbH

Successful handling of an accidental extravasation of 177Lu-PSMA-617 in the treatment of advanced prostate cancer

Michael Jüptner
1   Department of Nuclear Medicine, Molecular Diagnostic Imaging and Therapy, University Hospital of Schleswig-Holstein (UKSH), Campus Kiel, Germany
,
Maaz Zuhayra
1   Department of Nuclear Medicine, Molecular Diagnostic Imaging and Therapy, University Hospital of Schleswig-Holstein (UKSH), Campus Kiel, Germany
,
Isong Assam
2   Clinic of Radiotherapy, Department of Medical Physics, University Hospital of Schleswig-Holstein (UKSH), Campus Kiel, Germany
,
Ulf Lützen
1   Department of Nuclear Medicine, Molecular Diagnostic Imaging and Therapy, University Hospital of Schleswig-Holstein (UKSH), Campus Kiel, Germany
› Author Affiliations
Further Information

Publication History

received: 13 October 2017

accepted in revised form: 22 January 2018

Publication Date:
28 March 2018 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Hung JC, Ponto JA, Hammes RJ. Radiopharmaceutical-related pitfalls and artifacts. Semin Nucl Med 1996; 26: 208-255.
    CrossrefPubMedGoogle Scholar
  • 2 Poeppel TD, Boy C, Bockisch A, Kotzerke J, Buchmann I, Ezziddin S, Scheidhauer K, Krause BJ, Schmidt D, Amthauer H, Rösch F, Nagarajah J, Führer D, Lahner H, Pöpperl G, Hörsch D, Walter MA, Baum RP. Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1). Nuklearmedizin 2015; 54: 1-11.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Rahbar K, Ahmadzadehfar H, Kratochwil C, Haberkorn U, Schäfers M, Essler M, Baum RP, Kulkarni HR, Schmidt M, Drzezga A, Bartenstein P, Pfestroff A, Luster M, Lützen U, Marx M, Prasad V, Brenner W, Heinzel A, Mottaghy FM, Ruf J, Meyer PT, Heuschkel M, Eveslage M, Bögemann M, Fendler WP, Krause BJ. German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients. J Nucl Med 2017; 58: 85-90.
    CrossrefPubMedGoogle Scholar
  • 4 Schlenkhoff CD, Essler M, Ahmadzadehfar H. Possible Treatment Approach to an Extravasation of 177Lu-PSMA-617. Clin Nucl Med 2017; 42: 639-640.
    CrossrefPubMedGoogle Scholar
  • 5 van der Pol J, Vöö S, Bucerius J, Mottaghy FM. Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review. Eur J Nucl Med Mol Imaging 2017; 44: 1234-1243.
    CrossrefPubMedGoogle Scholar